PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany

Sandra Meyer-Moock,Daniel Szczotkowski,Leonie Schouten,Frank Petzke,Lena Milch,Beatrice Metz-Oster,Louise Zinndorf,Christian Geber,Greta Hoffmann,Anke Preißler,Ursula Marschall,Felix Rottke,Anja Waidner,André Möller,Thomas Isenberg,Gabriele Lindena,Anne Gärtner,Ulrike Kaiser,Thomas Kohlmann
DOI: https://doi.org/10.1186/s13063-024-07975-4
IF: 2.728
2024-02-25
Trials
Abstract:Up to 27% of the German population suffers from recurrent or persistent pain (lasting more than three months). Therefore, prevention of chronic pain is one major object of pain management interventions. The aim of this nationwide, multicentre, randomised controlled trial is to evaluate the efficacy of a 10-week ambulatory (outpatient) interdisciplinary multimodal pain therapy (A-IMPT) for patients with recurrent pain and at risk of developing chronic pain. This project was initiated by the German Pain Society (Deutsche Schmerzgesellschaft e.V.) and the public health insurance provider BARMER. It is currently funded by the German Innovation Fund (01NVF20023). The study PAIN2.0 focuses on reducing pain intensity and pain-related disability and investigates whether this intervention can improve physical activity, psychological well-being, and health literacy.
medicine, research & experimental
What problem does this paper attempt to address?